NURO Projected Dividend Yield
NeuroMetrix Inc ( NASDAQ : NURO )NeuroMetrix develops and commercializes health care products that utilize non-invasive neurostimulation. Co. designs, builds and markets medical devices that stimulate nerves and analyzes nerve response for diagnostic and therapeutic purposes. Co.'s products consist of a medical device used in conjunction with a consumable electrode or biosensor. Co.'s marketed products include: DPNCheck, which is a nerve conduction test that is used to evaluate evaluate peripheral neuropathies such as diabetic peripheral neuropathy; Quell, which is a wearable device for symptomatic relief of chronic pain; and ADVANCE System, which is a platform for the performance of nerve conduction studies. 20 YEAR PERFORMANCE RESULTS |
NURO Dividend History Detail NURO Dividend News NURO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |